South Korea Enteric Empty Capsules Market

South Korea Enteric Empty Capsules Market Insights Forecasts to 2035

• The Market Size is Expected to Grow at a CAGR of around 6.1% from 2025 to 2035
• The South Korea Enteric Empty Capsules Market Size Is Expected to Hold a Significant Share By 2035

According to a research report published by Dicision Advisors & Consulting, The South Korea Enteric Empty Capsules Market Size is anticipated to grow at a CAGR of 6.1% from 2025 to 2035. The market is growing in health consciousness, and the incidence of gastrointestinal disorders is driving up consumer demand for individualized and environmentally friendly health solutions.

Market Overview

The pharmaceutical excipients sector is referred to in the enteric empty capsule market, which produces special capsules designed with enteric coatings to evade the stomach acid and to release the active material in the intestine for better absorption and efficacy. In South Korea, the market for active empty capsules is gaining traction due to increasing demand for advanced drug distribution systems, an increase in the use of neutraceuticals and probiotics, and the country's expansion drug and biotechnology sectors. Manufacturers are focusing on high-quality gelatin and non-gelatin (HPMC, drawn) capsules to meet growing priority for vegetarian and allergen-free formulation. Regulatory support for innovation further increases the opportunity forms of oral solid dose forms and the strong export-oriented pharma industry of the country further.

Report Coverage

This research report categorizes the market for the South Korea enteric empty capsules market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea enteric empty capsules market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea enteric empty capsules market.

Driving Factors

The expanding use of probiotics and nutraceuticals, the growing acceptance of sophisticated drug delivery systems, and the growing consumer preference for vegetarian and allergy-free capsules. Market expansion is further accelerated by robust pharmaceutical R&D capabilities and government support for innovation.

Restraining Factors

Market expansion has been restricted by high manufacturing costs, stringent regulatory compliance requirements, price sensitivity, and fierce competition from manufacturers of generic capsules.

Market Segmentation

The South Korea enteric empty capsules market share is classified by product type and application

• The gelatin capsules segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea enteric empty capsules market is segmented by product type into gelatin capsules, non-gelatin capsules. Among these, the gelatin capsules segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Their efficiency in guaranteeing targeted release in the intestines and shielding active ingredients from stomach acids. They are produced using gelatin that comes from animals, which has superior solubility and bioavailability qualities.

• The pharmaceutical segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea enteric empty capsules market is segmented by application into pharmaceuticals, nutraceuticals, cosmetics, and others. Among these, the pharmaceutical segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing demand for systems of targeted drug delivery. Enteric empty capsules are frequently used to administer drugs that must be released in the intestines rather than the stomach's acidic environment. This is especially crucial for medications used to treat gastrointestinal issues, as well as for some enzyme supplements and antibiotics.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea enteric empty capsules market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Capsugel (Lonza)
• ACG Worldwide
• Suheung Co., Ltd.
• Roxlor LLC
• Farmacapsulas S.A.
• Nectar Lifesciences Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Dicision Advisors has segmented the South Korea enteric empty capsules market based on the below-mentioned segments:

South Korea Enteric Empty Capsules Market, By Product Type

• Gelatin Capsules
• Non-Gelatin Capsules

South Korea Enteric Empty Capsules Market, By Application

• Pharmaceuticals
• Nutraceuticals
• Cosmetics
• Others

FAQ

Q: What is the forecasted CAGR of the South Korea enteric empty capsules market from 2024 to 2035?
A: The market is expected to grow at a CAGR of around 6.1% during the period 2024–2035.

Q: Can you provide company profiles for the South Korea enteric empty capsules market?
A: Yes. For instance, Capsugel (Lonza), ACG Worldwide, Suheung Co., Ltd., Roxlor LLC, Farmacapsulas S.A., and Nectar Lifesciences Ltd.

Q: What are the main drivers of growth in the South Korea enteric empty capsules market?
A: Rising demand for advanced drug delivery, growing nutraceutical and probiotic consumption, and preference for vegetarian/non-gelatin capsules are key drivers.

Q: What challenges are limiting the adoption of enteric empty capsules in market?
A:  High manufacturing costs, strict regulatory standards, and pricing pressures from generics restrain growth.

Q: Which segment dominated the market?
A: The gelatin capsules segment dominated the market.